SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.39 CNY | -0.62% |
|
-4.95% | -28.58% |
| Jan. 10 | Kangtai Biological Forecasts Swing to Profit in 2023 | MT |
| 2023 | Shenzhen Kangtai Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
| Sales 2023 * | 3.69B 510M | Sales 2024 * | 4.81B 664M | Capitalization | 21.66B 2.99B |
|---|---|---|---|---|---|
| Net income 2023 * | 1.03B 142M | Net income 2024 * | 1.34B 186M | EV / Sales 2023 * | 6.02 x |
| Net Debt 2023 * | 581M 80.26M | Net Debt 2024 * | 57.28M 7.91M | EV / Sales 2024 * | 4.52 x |
| P/E ratio 2023 * |
20.6
x | P/E ratio 2024 * |
15.7
x | Employees | 2,018 |
| Yield 2023 * |
1.79% | Yield 2024 * |
2.2% | Free-Float | 51.45% |
More Fundamentals
* Assessed data
More news
More recommendations
| 1 day | -0.62% | ||
| 1 week | -5.18% | ||
| Current month | -11.42% | ||
| 1 month | -14.51% | ||
| 3 months | -16.99% | ||
| 6 months | -31.56% | ||
| Current year | -28.58% |
1 week
19.14
20.60
1 month
19.1422.67
Current year
18.4427.35
1 year
18.4434.18
3 years
18.44138.69
5 years
18.44156.06
10 years
1.82156.06
| Managers | Title | Age | Since |
|---|---|---|---|
Hui Zhou
DFI | Director of Finance/CFO | 52 | 21-12-29 |
Xiang Miao
PSD | President | 51 | 08-12-31 |
Wei Min Du
CHM | Chairman | 61 | 08-09-23 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jiao Yu Li
BRD | Director/Board Member | 66 | 21-12-28 |
Wei Min Du
CHM | Chairman | 61 | 08-09-23 |
Jian Kai Liu
BRD | Director/Board Member | 54 | 08-09-23 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.60% | 2 M€ | -18.13% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 19.39 | -0.62% | 10,420,340 |
| 24-04-24 | 19.51 | -1.86% | 9,911,123 |
| 24-04-23 | 19.88 | -1.14% | 9,383,245 |
| 24-04-22 | 20.11 | +0.85% | 8,987,833 |
| 24-04-19 | 19.94 | -2.25% | 7,909,049 |
End-of-day quote Shenzhen S.E., April 24, 2024
More quotes
Shenzhen Kangtai Biological Products Co. specialises in the research, development and marketing of human vaccines. Products include vaccines against hepatitis B, haemophilus influenzae type B, measles and rubella.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
19.39
CNY
Average target price
37.75
CNY
Spread / Average Target
+94.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -28.58% | 3.01B | |
| -2.86% | 87.31B | |
| +2.63% | 40.86B | |
| -21.76% | 29.36B | |
| +58.56% | 24.49B | |
| -14.78% | 17.31B | |
| -18.49% | 11.62B | |
| -15.61% | 11.31B | |
| -44.02% | 11.26B | |
| +5.17% | 8.31B |
- Stock Market
- Equities
- 300601 Stock
